MEDIA & PRESS

  • ESiNAR-X - Precise action in the treatment of leukaemia

    Research Features 2023

  • A tailor-made antiviral therapy for SARS-CoV-2

    Research Features 2022

  • Introducing a new generation of inhibitors to the oligonucleotide therapeutics market

    Innovation & Excellence Awards 2022

  • Young biotechnology company of the year

    Innovation & Excellence Awards 2022

  • Best MedTech innovation of the year - EU

    Research & Development Awards 2022

  • The Slovak medicine for COVID-19 is heading to the Medicines Agency

    NexTech 2022

error: Content is protected !!